Billion Dollar Blueprint: The Journey to Blockbuster Status – Infographic

Do the pharmaceutical industry’s billion-dollar drugs have an X-factor? To better understand the blockbuster landscape and identify the key characteristics driving their success, we’ve analysed Evaluate Pharma data on nearly 200 top-selling drugs. Get your copy of the Billion Dollar Blueprint infographic now to explore the essential data and insights behind the pharma industry’s powerhouses. […]

Share:

Download today








Do the pharmaceutical industry’s billion-dollar drugs have an X-factor?

To better understand the blockbuster landscape and identify the key characteristics driving their success, we’ve analysed Evaluate Pharma data on nearly 200 top-selling drugs.

Get your copy of the Billion Dollar Blueprint infographic now to explore the essential data and insights behind the pharma industry’s powerhouses.

Highlights

  • Discover which drugs are set to join the million dollar club
  • Uncover the therapy areas where innovation is yielding substantial returns
  • Uncover the therapy areas where innovation is yielding substantial returns.
  • Find out how long it takes for top-selling drugs to hit $1 billion, $5 billion, and beyond.
  • See whether it’s better to develop drugs in-house or through acquisitions and partnerships.

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content